---
abstract: With the improvement of therapeutic options for the treatment of breast
  cancer, the development of brain metastases has become a major limitation to life
  expectancy in many patients. Therefore, our aim was to identify molecular markers
  associated with the development of brain metastases in breast cancer.
authors: Wikman H, Lamszus K, Detels N, Uslar L, Wrage M, Benner C, Hohensee I, Ylstra
  B, Eylmann K, Zapatka M, Sauter G, Kemming D, Glatzel M, Muller V, Westphal M and
  Pantel K.
contact:
  email: ~
  name: Harriet Wikman
counts:
  biosamples: 40
  samples_acgh: 40
  samples_ccgh: 0
  samples_wes: 0
  samples_wgs: 0
external_identifiers:
- pubmed:22429330
- arrayexpress:E-MTAB-354
geo_data:
  geo_json:
    coordinates:
    - 10.02
    - 53.58
    type: Point
  info:
    city: Hamburg
    continent: Europe
    country: Germany
    label: Hamburg, Germany, Europe
    precision: city
journal: 'Breast Cancer Res 14, 2 (2012): R49.'
label: 'Wikman et al. (2012): Relevance of Pten Loss in Brain Metastasis Formation
  of Breast Cancer Patients.'
notes: ~
pmid: 22429330
title: Relevance of Pten Loss in Brain Metastasis Formation of Breast Cancer Patients.
year: 2012
